Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3369 Target Snapshot

Neprilysin · SINGLE PROTEIN · Rattus norvegicus

457Compounds
70Assays
0Approved Drugs
512.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P07861. Use UniProt P07861 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P07861 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Neprilysin as ChEMBL target CHEMBL3369, mapped to UniProt P07861. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Neprilysin
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3369
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P07861
Neprilysin
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Neprilysin is the right protein anchor across sources, using UniProt P07861 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNeprilysin
UniProt AccessionP07861
Component TypeProtein
Sequence Length750 aa

Neprilysin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Neprilysin, mapped to UniProt P07861. Sequence length is 750 aa.

Mapped IDP07861
Review nameNeprilysin
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

4
Phase II
Assay Mix

Activity Type Distribution

IC50465.0
KI47.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL353341 10.15 Ki 0.07 Preclinical
CHEMBL5283332 10.15 Ki 0.07 Preclinical
CHEMBL78429 10.15 Ki 0.07 Preclinical
CHEMBL5277842 10.1 Ki 0.08 Preclinical
CHEMBL63123 9.7 Ki 0.2 Preclinical
CHEMBL154588 9.57 IC50 0.27 Preclinical
CHEMBL294536 9.52 Ki 0.3 Preclinical
CHEMBL304233 9.4 Ki 0.4 Preclinical
CHEMBL366495 9.4 Ki 0.4 Preclinical
CHEMBL165980 9.39 IC50 0.41 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
22
5.5
55
6.0
50
6.5
57
7.0
66
7.5
73
8.0
62
8.5
23
9.0
3
9.5
pChEMBL
Assay Landscape

Assay Landscape

70
Total Assays
380
Tested Compounds
2
Assay Types
Binding — 67 assays, 380 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 53 313 7.4
cell membrane format 5 29 7.4
assay format 4 22 7.0
tissue-based format 3 15 8.1
organism-based format 2 1
Functional — 3 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 2 10 8.8
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine